BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
ev3 is defunct.

Fate: Acquired by Covidien, Jul 2010, $2.6B


------------------
If you believe any of this information is incorrect, please let us know.